mRNA-based COVID vaccines generate improved responses to immunotherapy
Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice as likely to be alive three years after beginning treatment, according to a new study led by researchers ...
Oct 19, 2025
0
242









